Glypican-3 Expression in Patients with Oral Squamous Cell Carcinoma

Glypican-3 Expression in Patients with Oral Squamous Cell Carcinoma

Statement of the Problem: Oral squamous cell carcinoma (OSCC) is a malignant neoplasm that affects the structures or tissues of mouth. Early diagnosis of these tumors is important to improve the outcome of treatment. Therefore, using pathological techniques based on molecular markers may be useful f...

Full description

Bibliographic Details
Main Authors:	Azadeh Andisheh Tadbir, Amir Saeed Goharian, Mohammad Ali Ranjbar
Format:	Article
Language:	English
Published:	Shiraz University of Medical Sciences 2020-06-01
Series:	Journal of Dentistry
Subjects:	glypican-3; immunohistochemistry; squamous cell carcinoma
Online Access:	http://dentjods.sums.ac.ir/article_45902.html

Similar Items

IMMUNOHISTOCHEMICAL EXPRESSION OF GLYPICAN-3 IN HEPATOCELLULAR CARCINOMA
by: Dr Syed Salman Ali, et al.
Published: (2018-08-01)

Glypican-3 Differentiates Intraductal Carcinoma and Paget’s Disease from Other Types of Breast Cancer
by: Fatemah OFO Alshammari, et al.
Published: (2022-12-01)

A glypican-1-targeted antibody-drug conjugate exhibits potent tumor growth inhibition in glypican-1-positive pancreatic cancer and esophageal squamous cell carcinoma
by: Eri Munekage, et al.
Published: (2021-09-01)

Increased Glypican-3 immunostaining is associated with longer survival outcomes in colorectal carcinoma
by: Jaudah Al-Maghrabi, et al.
Published: (2022-06-01)

Glypican 3-Targeted Therapy in Hepatocellular Carcinoma
by: Takahiro Nishida, et al.
Published: (2019-09-01)

The prognostic value of arginase-1 and glypican-3 expression levels in patients after surgical intrahepatic cholangiocarcinoma resection
by: Zeyuan Qiang, et al.
Published: (2021-10-01)

Glypican-3-Targeted Alpha Particle Therapy for Hepatocellular Carcinoma
by: Meghan M. Bell, et al.
Published: (2020-12-01)

Intratumoral reciprocal expression of monocarboxylate transporter 4 and glypican-3 in hepatocellular carcinomas
by: Kenji Yorita, et al.
Published: (2019-11-01)

Serum Endostatin Levels in Oral Squamous Cell Carcinoma
by: Maryam Mardani, et al.
Published: (2018-05-01)

Experimental Validation of Novel Glypican 3 Exosomes for the Detection of Hepatocellular Carcinoma in Liver Cirrhosis
by: Aydin Y, et al.
Published: (2021-12-01)

Glypican-3: A molecular marker for the detection and treatment of hepatocellular carcinoma
by: Tsung-Chieh Shih, et al.
Published: (2020-12-01)

Multiparametric MRI combined with clinical factors to predict glypican-3 expression of hepatocellular carcinoma
by: Peijun Liu, et al.
Published: (2023-11-01)

Experimental Validation of Novel Glypican 3 Exosomes for the Detection of Hepatocellular Carcinoma in Liver Cirrhosis [Corrigendum]
by: Aydin Y, et al.
Published: (2022-08-01)

Glypican-3 Expression in Breast Cancer
by: Ching-Hua Tsai, et al.
Published: (2015-12-01)

Impaired Autophagy Response in Hepatocellular Carcinomas Enriches Glypican-3 in Exosomes, Not in the Microvesicles
by: Koksal AR, et al.
Published: (2022-09-01)

Assessment of glypican-3 immune expression in ameloblastoma, ameloblastic fibroma, ameloblastic carcinoma (pilot study)
by: Nayl Ahmed Al-ezzi Al-Malahy, et al.
Published: (2024-03-01)

MAY GLYPICAN-3 BE A NOVEL BIOMARKER AND POTENTIAL THERAPEUTIC TARGET IN HEPATOCELLULAR CANCER?
by: Irina I. Ivanova
Published: (2018-03-01)

Diagnostic accuracy and prognostic significance of Glypican-3 in hepatocellular carcinoma: A systematic review and meta-analysis
by: Donglei Jiang, et al.
Published: (2022-09-01)

Preoperative prediction of glypican-3 positive expression in solitary hepatocellular carcinoma on gadoxetate-disodium enhanced magnetic resonance imaging
by: Yidi Chen, et al.
Published: (2022-08-01)

Evaluation of the Ki-67 and MCM3 Expression in Cytologic Smear of Oral Squamous Cell Carcinoma
by: Fahimeh Rezazadeh, et al.
Published: (2017-09-01)

Glypican-3 (GPC-3) Structural Analysis and Cargo in Serum Small Extracellular Vesicles of Hepatocellular Carcinoma Patients
by: Montalbano Mauro, et al.
Published: (2023-06-01)

Serum Level of Galectin-3 in Patients withOral Squamous Cell Carcinoma
by: Yasaman Sardari, et al.
Published: (2010-04-01)

Prognostic value of S100A4 and Glypican-3 in hepatocellular carcinoma in cirrhotic HCV patients
by: Mahmoud El-Bendary, et al.
Published: (2023-08-01)

Value of Glypican-1 Expression in Pleural Epithelioid Mesothelioma, Adenocarcinoma and Squamous Cell Carcinoma of the Lung
by: Noha ED Hassab El-Naby, et al.
Published: (2023-05-01)

Effects of hepatitis C virus NS3 protein on expression of heat shock protein 70 and Glypican3 as the markers of hepatocellular carcinoma
by: Sepideh Saeb, et al.
Published: (2021-12-01)

A Statistical Approach to the Diagnosis and Prediction of HCC Using CK19 and Glypican 3 Biomarkers
by: Călin Burciu, et al.
Published: (2023-03-01)

Distinct diagnostic and prognostic values of Glypicans gene expression in patients with hepatocellular carcinoma
by: Jian-Yao Wang, et al.
Published: (2021-04-01)

Can glypican-3 be a disease-specific biomarker?
by: Chaolei Chen, et al.
Published: (2017-05-01)

Glypican-3 level assessed by the enzyme-linked immunosorbent assay is inferior to alpha-fetoprotein level for hepatocellular carcinoma diagnosis
by: Yejoo Jeon, et al.
Published: (2016-09-01)

Overexpression of Lysosome-Associated Membrane Protein 1 in Oral Squamous Cell Carcinoma and its Correlation with Tumor Differentiation and Metastasis
by: Mohammad Ali Ranjbar, et al.
Published: (2022-01-01)

Glypican-3: A Novel and Promising Target for the Treatment of Hepatocellular Carcinoma
by: Xiufeng Zheng, et al.
Published: (2022-02-01)

The analysis of expression of HAase in oral squamous cell carcinoma
by: WANG Jingxu, et al.
Published: (2017-10-01)

Immunohistochemical Evaluation of Fascin in Oral Squamous Cell Carcinoma
by: Najmeh Jafari, et al.
Published: (2020-07-01)

A nomogram based on LI-RADS features, clinical indicators and quantitative contrast-enhanced MRI parameters for predicting glypican-3 expression in hepatocellular carcinoma
by: Yan Song, et al.
Published: (2023-02-01)

Pentagone internalises glypicans to fine-tune multiple signalling pathways
by: Mark Norman, et al.
Published: (2016-06-01)

Immunological efficacy of glypican-3 peptide vaccine in patients with advanced hepatocellular carcinoma
by: Nobuhiro Tsuchiya, et al.
Published: (2017-10-01)

Peptide-Conjugated Aggregation-Induced Emission Fluorogenic Probe for Glypican-3 Protein Detection and Hepatocellular Carcinoma Cells Imaging
by: Song Zhang, et al.
Published: (2022-05-01)

Immunohistochemical expression of cyclooxygenase-2 in oral squamous cell carcinoma
by: Nirupa Thomas, et al.
Published: (2019-01-01)

Delta-radiomics models based on multi-phase contrast-enhanced magnetic resonance imaging can preoperatively predict glypican-3-positive hepatocellular carcinoma
by: Zewen Han, et al.
Published: (2023-08-01)

Novel Nanotechnology Approaches to Overcome Drug Resistance in the Treatment of Hepatocellular Carcinoma: Glypican 3 as a Useful Target for Innovative Therapies
by: Monica Mossenta, et al.
Published: (2022-09-01)